Pediatrix Medical Group (MD) Projected to Post Earnings on Tuesday

Pediatrix Medical Group (NYSE:MD) is expected to be releasing its Q1 2026 results before the market opens on Tuesday, May 5th. Analysts expect Pediatrix Medical Group to post earnings of $0.37 per share and revenue of $465.8280 million for the quarter. Parties may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Tuesday, May 5, 2026 at 9:00 AM ET.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Thursday, February 19th. The company reported $0.50 EPS for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.03). The company had revenue of $493.77 million during the quarter, compared to analysts’ expectations of $486.23 million. Pediatrix Medical Group had a return on equity of 19.59% and a net margin of 8.64%.The company’s revenue was down 1.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.51 earnings per share. On average, analysts expect Pediatrix Medical Group to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Pediatrix Medical Group Price Performance

MD opened at $22.72 on Monday. The firm has a market cap of $1.89 billion, a PE ratio of 11.71 and a beta of 0.70. The stock has a 50-day moving average price of $20.96 and a 200-day moving average price of $21.21. Pediatrix Medical Group has a 1 year low of $11.84 and a 1 year high of $24.99. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.66.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on MD. Truist Financial raised their price objective on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research note on Monday, April 13th. UBS Group dropped their target price on shares of Pediatrix Medical Group from $23.00 to $22.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 24th. Zacks Research downgraded shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 23rd. Deutsche Bank Aktiengesellschaft set a $19.00 price objective on shares of Pediatrix Medical Group in a report on Friday, February 20th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Two analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $21.33.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Invesco Ltd. grew its position in Pediatrix Medical Group by 24.4% in the 4th quarter. Invesco Ltd. now owns 1,090,655 shares of the company’s stock worth $23,329,000 after purchasing an additional 213,636 shares during the period. State of Tennessee Department of Treasury lifted its holdings in shares of Pediatrix Medical Group by 2.8% during the 4th quarter. State of Tennessee Department of Treasury now owns 46,016 shares of the company’s stock valued at $984,000 after buying an additional 1,246 shares during the period. EP Wealth Advisors LLC bought a new position in shares of Pediatrix Medical Group during the 4th quarter valued at $472,000. Mackenzie Financial Corp boosted its stake in shares of Pediatrix Medical Group by 35.7% in the 4th quarter. Mackenzie Financial Corp now owns 55,150 shares of the company’s stock worth $1,201,000 after buying an additional 14,502 shares during the last quarter. Finally, Empowered Funds LLC grew its holdings in shares of Pediatrix Medical Group by 17.8% in the fourth quarter. Empowered Funds LLC now owns 622,380 shares of the company’s stock worth $13,313,000 after acquiring an additional 93,833 shares during the period. Institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.